Articles related to PATIENT MONITORING

Medicare reimbursement for RPM remains lowest in rural areas where chronic disease prevalence exceeds national averages and provider access presents significant challenges.

The investigation’s state-specific nature suggests potential localized factors, as similar adverse events have not been reported in other regions.

Monthly hepatic monitoring becomes mandatory for the first three months of Veozah therapy, marking a significant shift in safety protocols for menopausal vasomotor symptom management.

Extended cardiac monitoring after stroke can significantly increase AFib detection rates, potentially altering the course of secondary stroke prevention strategies.

New-onset diabetes in patients over 50 may serve as an early warning sign of pancreatic cancer, with research showing a 1-3 year presence of diabetes before cancer diagnosis in many cases.

Medication-induced ocular complications can occur across multiple drug classes, with risk factors including dosage, duration of treatment, and individual patient susceptibility.